TBPH icon

Theravance Biopharma

115 hedge funds and large institutions have $439M invested in Theravance Biopharma in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 43 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership:

more funds holding in top 10

Funds holding in top 10:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

20% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 15

30% less repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 43

Holders
115
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.18M
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$2.65M
2 +$2.64M
3 +$2.27M
4
HCM
Highbridge Capital Management
New York
+$1.96M
5
Millennium Management
Millennium Management
New York
+$1.81M

Top Sellers

1 -$8.19M
2 -$5.63M
3 -$4.67M
4
BlackRock
BlackRock
New York
-$4.44M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$3.28M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$64.4M
2
$64M
3
$60.5M
4
$39.4M
5
$33.1M
6
$23.8M
7
$17.3M
8
$17.1M
9
$15.9M
10
$12.7M
11
$9.16M
12
$8.23M
13
$5.95M
14
$4.97M
15
$4.8M
16
$3.97M
17
$3.52M
18
$2.83M
19
$2.81M
20
$2.61M
21
$2.48M
22
$2.33M
23
$2.18M
24
$2.18M
25
$1.96M